Loading
SEC Form 13F · Q2 2026
Farallon Capital Mgmt portfolio
Andrew Spokes · FARALLON CAPITAL MANAGEMENT LLC · CIK 0000909661
Latest 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026, compared with the quarter ended Mar 31, 2026.
Reported 13F value$21.7B
Holdings89
Top 10 concentration43.9%
New positions23
Added to29
Reduced23
Closed107
What changed in Q2 2026
Estimated trade value from reported units and period-end values
New positions
Added to
Reduced
Closed
Holdings, Q2 2026
89 positions by reported value · includes 3 option positions
| Holding | Portfolio weight | Reported value | Shares / units | Change vs prior quarter |
|---|---|---|---|---|
| SPYSTATE STR SPDR S&P 500 ETF T · TR UNIT · PUT | 20.67% | $4.5B | 6,000,000 | New |
| RVMDREVOLUTION MEDICINES INC · COM | 11.71% | $2.5B | 13,550,796 | -0.4% |
| EA*ELECTRONIC ARTS INC · COM | 7.49% | $1.6B | 7,919,500 | +6.0% |
| BBIOBRIDGEBIO PHARMA INC · COM | 3.69% | $800.1M | 10,743,063 | +14.7% |
| PTGXPROTAGONIST THERAPEUTICS INC · COM | 3.59% |
Source: SEC Form 13F filings (latest filing on sec.gov). Information and analytics, not investment advice. Holdings are reported as of the quarter end, not live positions; reported 13F value covers securities listed on Form 13F and is not the fund's total assets under management.